|Number of Estimates|
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.
Market Cap: 11.9 Billion
Primary Exchange: NASDAQ
Shares Outstanding: 45 Million
Float: 44 Million
Sector: Health Technology
Industry: Medical Specialties
Longest drawdown: 468 trading days
From: 2018-09-28 To: 2020-07-14
Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women's Health
via: Business Wire at 2019-06-13 10:00:00:000
Abiomeds(NASDAQ:ABMD) Impella platform is being featured today at a Washington, D.C., event showcasing innovations in medical technology that improve healthcare for women. Abiomeds participation supports its Womens Initiative for Heart Recovery , which provid… read more...
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|